These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 27270211)
1. Harnessing mesenchymal stem cell homing as an anticancer therapy. Hagenhoff A; Bruns CJ; Zhao Y; von Lüttichau I; Niess H; Spitzweg C; Nelson PJ Expert Opin Biol Ther; 2016 Sep; 16(9):1079-92. PubMed ID: 27270211 [TBL] [Abstract][Full Text] [Related]
2. Selective targeting of genetically engineered mesenchymal stem cells to tumor stroma microenvironments using tissue-specific suicide gene expression suppresses growth of hepatocellular carcinoma. Niess H; Bao Q; Conrad C; Zischek C; Notohamiprodjo M; Schwab F; Schwarz B; Huss R; Jauch KW; Nelson PJ; Bruns CJ Ann Surg; 2011 Nov; 254(5):767-74; discussion 774-5. PubMed ID: 22042469 [TBL] [Abstract][Full Text] [Related]
3. Linking transgene expression of engineered mesenchymal stem cells and angiopoietin-1-induced differentiation to target cancer angiogenesis. Conrad C; Hüsemann Y; Niess H; von Luettichau I; Huss R; Bauer C; Jauch KW; Klein CA; Bruns C; Nelson PJ Ann Surg; 2011 Mar; 253(3):566-71. PubMed ID: 21169810 [TBL] [Abstract][Full Text] [Related]
4. Genetically engineered mesenchymal stromal cells in cancer gene therapy. Matuskova M; Durinikova E; Altaner C; Kucerova L Bratisl Lek Listy; 2018; 119(4):221-223. PubMed ID: 29663820 [TBL] [Abstract][Full Text] [Related]
5. Engineered mesenchymal stem cells as vectors in a suicide gene therapy against preclinical murine models for solid tumors. Amara I; Pramil E; Senamaud-Beaufort C; Devillers A; Macedo R; Lescaille G; Seguin J; Tartour E; Lemoine FM; Beaune P; de Waziers I J Control Release; 2016 Oct; 239():82-91. PubMed ID: 27565211 [TBL] [Abstract][Full Text] [Related]
6. The future of mesenchymal stem cell-based therapeutic approaches for cancer - From cells to ghosts. Mohr A; Zwacka R Cancer Lett; 2018 Feb; 414():239-249. PubMed ID: 29175461 [TBL] [Abstract][Full Text] [Related]
7. Programming hMSCs into Potential Genetic Therapy in Cancer. Serakinci N; Cagsin H Crit Rev Eukaryot Gene Expr; 2019; 29(4):343-350. PubMed ID: 31679295 [TBL] [Abstract][Full Text] [Related]
8. Mesenchymal Stem Cell Expressing TRAIL as Targeted Therapy against Sensitised Tumour. Fakiruddin KS; Ghazalli N; Lim MN; Zakaria Z; Abdullah S Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30060445 [TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stem cell: a new horizon in cancer gene therapy. Mohammadi M; Jaafari MR; Mirzaei HR; Mirzaei H Cancer Gene Ther; 2016 Sep; 23(9):285-6. PubMed ID: 27650780 [TBL] [Abstract][Full Text] [Related]
10. The role of mesenchymal stem cells in oncology and regenerative medicine. Khan M; Adil SE; Olson AL Future Oncol; 2017 Apr; 13(9):821-831. PubMed ID: 27908206 [TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cells in cancer: tumor-associated fibroblasts and cell-based delivery vehicles. Hall B; Dembinski J; Sasser AK; Studeny M; Andreeff M; Marini F Int J Hematol; 2007 Jul; 86(1):8-16. PubMed ID: 17675260 [TBL] [Abstract][Full Text] [Related]
12. Concise review: genetically engineered stem cell therapy targeting angiogenesis and tumor stroma in gastrointestinal malignancy. Keung EZ; Nelson PJ; Conrad C Stem Cells; 2013 Feb; 31(2):227-35. PubMed ID: 23132810 [TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stem cell-mediated, tumor stroma-targeted radioiodine therapy of metastatic colon cancer using the sodium iodide symporter as theranostic gene. Knoop K; Schwenk N; Schmohl K; Müller A; Zach C; Cyran C; Carlsen J; Böning G; Bartenstein P; Göke B; Wagner E; Nelson PJ; Spitzweg C J Nucl Med; 2015 Apr; 56(4):600-6. PubMed ID: 25745085 [TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cell-based therapy for nonhealing wounds: today and tomorrow. Li M; Zhao Y; Hao H; Han W; Fu X Wound Repair Regen; 2015; 23(4):465-82. PubMed ID: 25877885 [TBL] [Abstract][Full Text] [Related]
16. Cytotherapies in multiple myeloma: a complementary approach to current treatments? Ciavarella S; Caselli A; Savonarola A; Tamma AV; Tucci M; Silvestris F Expert Opin Biol Ther; 2013 Jun; 13 Suppl 1():S23-34. PubMed ID: 23701130 [TBL] [Abstract][Full Text] [Related]
17. Cancer gene therapy using mesenchymal stem cells. Uchibori R; Tsukahara T; Ohmine K; Ozawa K Int J Hematol; 2014 Apr; 99(4):377-82. PubMed ID: 24578184 [TBL] [Abstract][Full Text] [Related]
18. The application of mRNA-based gene transfer in mesenchymal stem cell-mediated cytotoxicity of glioma cells. Guo XR; Yang ZS; Tang XJ; Zou DD; Gui H; Wang XL; Ma SN; Yuan YH; Fang J; Wang B; Zhang L; Sun XY; Warnock GL; Dai LJ; Tu HJ Oncotarget; 2016 Aug; 7(34):55529-55542. PubMed ID: 27487125 [TBL] [Abstract][Full Text] [Related]
19. TRAIL based therapy: overview of mesenchymal stem cell based delivery and miRNA controlled expression of TRAIL. Attar R; Sajjad F; Qureshi MZ; Tahir F; Hussain E; Fayyaz S; Farooqi AA Asian Pac J Cancer Prev; 2014; 15(16):6495-7. PubMed ID: 25169476 [TBL] [Abstract][Full Text] [Related]